Selank

Selank is a synthetic heptapeptide derived from the tetrapeptide Tuftsin with a Pro-Gly-Pro stabilizing extension. Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, it has been referenced in published preclinical literature. Manufactured to ≥99% purity with third-party verification.

Selank is a synthetic heptapeptide derived from Tuftsin with a Pro-Gly-Pro stabilizing extension. Developed at the Russian Academy of Sciences, it has been referenced in published preclinical literature. Supplied as a high-purity lyophilized research peptide.

Selank was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It was designed by combining the tetrapeptide Tuftsin (Thr-Lys-Pro-Arg) with a stabilizing Pro-Gly-Pro C-terminal extension. Published research from Russian academic institutions has referenced this compound since the 1990s.

This peptide carries the True Research Certified designation, awarded exclusively to compounds that achieve verified ≥99% purity through independent third-party HPLC and mass spectrometry analysis. True Research Certified products undergo batch-level endotoxin screening via the LAL (Limulus Amebocyte Lysate) method and are accompanied by a comprehensive Certificate of Analysis (COA) documenting purity, identity, and endotoxin results. This certification reflects our commitment to supplying only the highest-grade research materials to the scientific community.